[Federal Register Volume 87, Number 21 (Tuesday, February 1, 2022)]
[Notices]
[Page 5483]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-01949]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP)--RFA-CE-22-001, Grants To Support New 
Investigators in Conducting Research Related to Understanding Polydrug 
Use Risk and Protective Factors; Cancellation of Meeting

AGENCY: Centers for Disease Control and Prevention, Department of 
Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUPPLEMENTARY INFORMATION: Notice is hereby given of a change in the 
meeting of the Disease, Disability, and Injury Prevention and Control 
Special Emphasis Panel (SEP)--RFA-CE-22-001, Grants to Support New 
Investigators in Conducting Research Related to Understanding Polydrug 
Use Risk and Protective Factors; March 15-16, 2022, 8:30 a.m.-5:30 
p.m., EDT. The web conference was published in the Federal Register on 
January 5, 2022, Volume 87, Number 3, page 460.
    This meeting is being canceled in its entirety.

FOR FURTHER INFORMATION CONTACT: Aisha L. Wilkes, M.P.H., Scientific 
Review Officer, National Center for Injury Prevention and Control, CDC, 
4770 Buford Highway NE, Mailstop S106-9, Atlanta, Georgia 30341-3717, 
Telephone: (404) 639-6473, Email: [email protected].
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-01949 Filed 1-31-22; 8:45 am]
BILLING CODE 4163-18-P